These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 34313784)
101. Model membranes to shed light on the biochemical and physical properties of ezrin/radixin/moesin. Maniti O; Carvalho K; Picart C Biochimie; 2013 Jan; 95(1):3-11. PubMed ID: 23041444 [TBL] [Abstract][Full Text] [Related]
102. Reduced P-glycoprotein recognition of a radioiodine-labeled phosphonium cation by stilbenylation for mitochondrial membrane potential based-imaging. Suzuki C; Sakai T; Magata Y Bioorg Med Chem; 2023 Apr; 84():117260. PubMed ID: 37003156 [TBL] [Abstract][Full Text] [Related]
104. The expression and clinical significance of an Epithelial-Mesenchymal Transition inducer, SNAI1, in head and neck carcinoma. Zhao H; Ling J; Huang Y; Chang A; Zhuo X J Oral Pathol Med; 2021 Feb; 50(2):145-154. PubMed ID: 32945534 [TBL] [Abstract][Full Text] [Related]
105. Moesin affects the plasma membrane expression and the immune checkpoint function of CD47 in human ovarian clear cell carcinoma. Ito Y; Kobori T; Urashima Y; Ito T; Hotta K; Obata T J Reprod Immunol; 2024 Feb; 161():104185. PubMed ID: 38141516 [TBL] [Abstract][Full Text] [Related]
106. Telencephalin protects PAJU cells from amyloid beta protein-induced apoptosis by activating the ezrin/radixin/moesin protein family/phosphatidylinositol-3-kinase/protein kinase B pathway. Yang H; Wu D; Zhang X; Wang X; Peng Y; Hu Z Neural Regen Res; 2012 Oct; 7(28):2189-98. PubMed ID: 25538739 [TBL] [Abstract][Full Text] [Related]
107. Bisecting GlcNAc modification reverses the chemoresistance via attenuating the function of P-gp. Tan Z; Ning L; Cao L; Zhou Y; Li J; Yang Y; Lin S; Ren X; Xue X; Kang H; Li X; Guan F Theranostics; 2024; 14(13):5184-5199. PubMed ID: 39267774 [No Abstract] [Full Text] [Related]
108. Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer. Hoffmann H; Wartenberg M; Vorlova S; Karl-Schöller F; Kallius M; Reinhardt O; Öztürk A; Schuhmair LS; Burkhardt V; Gätzner S; Scheld D; Nandigama R; Zernecke A; Herterich S; Ergün S; Rosenwald A; Henke E Oncogene; 2024 Aug; 43(35):2661-2676. PubMed ID: 39095583 [TBL] [Abstract][Full Text] [Related]
109. Tunicamycin depresses P-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in L1210 cells. Sereš M; Cholujová D; Bubenčíkova T; Breier A; Sulová Z Int J Mol Sci; 2011; 12(11):7772-84. PubMed ID: 22174631 [TBL] [Abstract][Full Text] [Related]
110. Possible Regulation of P-glycoprotein Function by Adrenergic Agonists in a Vascular-luminal Perfused Preparation of Small Intestine. Mukai H; Takanashi M; Ogawara KI; Maruyama M; Higaki K J Pharm Sci; 2021 Dec; 110(12):3889-3895. PubMed ID: 34530005 [TBL] [Abstract][Full Text] [Related]
111. Microbial Metabolites Orchestrate a Distinct Multi-Tiered Regulatory Network in the Intestinal Epithelium That Directs P-Glycoprotein Expression. Foley SE; Dente MJ; Lei X; Sallis BF; Loew EB; Meza-Segura M; Fitzgerald KA; McCormick BA mBio; 2022 Aug; 13(4):e0199322. PubMed ID: 35968955 [TBL] [Abstract][Full Text] [Related]
112. The calcium channel proteins ORAI3 and STIM1 mediate TGF-β induced Bhattacharya A; Kumar J; Hermanson K; Sun Y; Qureshi H; Perley D; Scheidegger A; Singh BB; Dhasarathy A Oncotarget; 2018 Jun; 9(50):29468-29483. PubMed ID: 30034631 [TBL] [Abstract][Full Text] [Related]
113. Rifabutin but not rifampicin can partly out-balance P-glycoprotein induction by concurrent P-glycoprotein inhibition through high affinity binding to the inhibitory site. Phondeth L; Kamaraj R; Nilles J; Weiss J; Haefeli WE; Pávek P; Theile D Arch Toxicol; 2024 Jan; 98(1):223-231. PubMed ID: 37833491 [TBL] [Abstract][Full Text] [Related]
114. Cryo-EM structure of P-glycoprotein bound to triple elacridar inhibitor molecules. Hamaguchi-Suzuki N; Adachi N; Moriya T; Yasuda S; Kawasaki M; Suzuki K; Ogasawara S; Anzai N; Senda T; Murata T Biochem Biophys Res Commun; 2024 May; 709():149855. PubMed ID: 38579618 [TBL] [Abstract][Full Text] [Related]
115. Unveiling the Correlation Between the Membrane Assembly of P-gp and Drug Resistance in Multiple Myeloma Using Super-Resolution Fluorescence Imaging. Chen J; Du Y; Hou H; Li W; Sun C; Liang F; Wang H Anal Chem; 2024 Jul; 96(29):11673-11681. PubMed ID: 38994836 [TBL] [Abstract][Full Text] [Related]
116. MYBL2 accelerates epithelial-mesenchymal transition and hepatoblastoma metastasis via the Smad/SNAI1 pathway. Wei M; Yang R; Ye M; Zhan Y; Liu B; Meng L; Xie L; Du M; Wang J; Gao R; Chen D; Dong R; Dong K Am J Cancer Res; 2022; 12(5):1960-1981. PubMed ID: 35693071 [TBL] [Abstract][Full Text] [Related]
117. Study Models of Drug-Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels. Veiga-Matos J; Morales AI; Prieto M; Remião F; Silva R Molecules; 2023 Nov; 28(22):. PubMed ID: 38005253 [TBL] [Abstract][Full Text] [Related]
118. Radixin modulates the plasma membrane localization of CD47 in human uterine cervical adenocarcinoma cells. Kobori T; Ito Y; Doukuni R; Urashima Y; Ito T; Obata T J Reprod Immunol; 2023 Aug; 158():103982. PubMed ID: 37364502 [TBL] [Abstract][Full Text] [Related]
119. SNAI1 is a prognostic biomarker and correlated with immune infiltrates in gastrointestinal cancers. Fang J; Ding Z Aging (Albany NY); 2020 Aug; 12(17):17167-17208. PubMed ID: 32833672 [TBL] [Abstract][Full Text] [Related]
120. High-performance cation electrokinetic concentrator based on a γ-CD/QCS/PVA composite and microchip for evaluating the activity of P-glycoprotein without any interference from serum albumin. Zhang R; Xu J; Deng J; Ouyang W; Chen H; Tang Q; Zheng S; Liu L Lab Chip; 2023 Dec; 24(1):127-136. PubMed ID: 38073277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]